Natixis Investment Managers International’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Natixis Investment Managers International's ELV Position: Q3 2022 in Review
Natixis Investment Managers International sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 4,013 shares — an estimated $1.95M sold.
Natixis Investment Managers International first reported a position in ELV in Q2 2015 and held it in 15 quarters. The position peaked at $2.63M in Q3 2018. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.
- Natixis Investment Managers International reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 4,013 Elevance Health shares in Q3 2022, an estimated $1.95M.
- Natixis Investment Managers International first reported a position in Elevance Health in Q2 2015 and held it in 15 quarters.
- Natixis Investment Managers International's Elevance Health position peaked at $2.63M in Q3 2018.
- 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.
Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.